{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T17:02:46Z","timestamp":1763226166632},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T00:00:00Z","timestamp":1405296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0102112","type":"journal-article","created":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T18:05:02Z","timestamp":1405361102000},"page":"e102112","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["DNA Repair Biomarkers XPF and Phospho-MAPKAP Kinase 2 Correlate with Clinical Outcome in Advanced Head and Neck Cancer"],"prefix":"10.1371","volume":"9","author":[{"given":"Tanguy Y.","family":"Seiwert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoZhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Heitmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Villegas-Bergazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kam","family":"Sprott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"O'Regan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan D.","family":"Farrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph R.","family":"Weichselbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark W.","family":"Lingen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezra E. W.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Stenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everett E.","family":"Vokes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,7,14]]},"reference":[{"key":"ref1","volume":"127","unstructured":"Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, et al<\/etal>.. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127<\/volume>: : 2893\u20132917. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21351269<\/ext-link>. Accessed 2012 Oct 4."},{"key":"ref2","volume":"59","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al<\/etal>.. (n.d.) Cancer statistics, 2009. CA Cancer J Clin 59<\/volume>: : 225\u2013249. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19474385<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref3","volume":"4","unstructured":"Seiwert TY, Salama JK, Vokes EE (2007) The chemoradiation paradigm in head and neck cancer. Nat Clin Pract Oncol 4<\/volume>: : 156\u2013171. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17327856<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref4","volume":"25","unstructured":"Salama JK, Seiwert TY, Vokes EE (2007) Chemoradiotherapy for locally advanced head and neck cancer. J Clin Oncol 25<\/volume>: : 4118\u20134126. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17827462<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref5","volume":"19","unstructured":"Salama JK, Stenson KM, Kistner EO, Mittal BB, Argiris A, et al<\/etal>.. (2008) Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels. Ann Oncol 19<\/volume>: : 1787\u20131794. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18539617<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref6","volume":"18","unstructured":"Vokes EE, Kies MS, Haraf DJ, Stenson K, List M, et al<\/etal>.. (2000) Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 18<\/volume>: : 1652\u20131661. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10764425<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref7","volume":"100","unstructured":"Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, et al<\/etal>.. (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100<\/volume>: : 261\u2013269. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18270337<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref8","volume":"14","unstructured":"Haddad R, O'Neill A, Rabinowits G, Tishler R, Khuri F, et al<\/etal>.. (2013) Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol 14<\/volume>: : 257\u2013264. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23414589<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref9","volume":"355","unstructured":"Pignon JP, Bourhis J, Domenge C, Design\u00e9 L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355<\/volume>: : 949\u2013955. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10768432<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref10","volume":"131","unstructured":"Alter BP, Joenje H, Oostra AB, Pals G (2005) Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism. Arch Otolaryngol Head Neck Surg 131<\/volume>: : 635\u2013639. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16027289<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref11","volume":"131","unstructured":"Van Waes C (2005) Head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg 131<\/volume>: : 640\u2013641.Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16027290<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref12","volume":"105","unstructured":"Rosenberg PS, Soci\u00e9 G, Alter BP, Gluckman E (2005) Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 105<\/volume>: : 67\u201373. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15331448<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref13","volume":"134","unstructured":"He Y, Chen Q, Li B (2008) ATM in oral carcinogenesis: association with clinicopathological features. J Cancer Res Clin Oncol 134<\/volume>: : 1013\u20131020. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18288488<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref14","volume":"65","unstructured":"Van Zeeburg HJT, Snijders PJF, Pals G, Hermsen MAJA, Rooimans MA, et al<\/etal>.. (2005) Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients. Cancer Res 65<\/volume>: : 1271\u20131276. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15735012<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref15","volume":"98","unstructured":"Berkower AS, Biller HF (1988) Head and neck cancer associated with Bloom's syndrome. Laryngoscope 98<\/volume>: : 746\u2013748. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3290604<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Iguchi H, Takayama M, Kusuki M, Sunami K, Nakamura A, et al<\/etal>.. (2004) A possible case of Werner syndrome presenting with multiple cancers. Acta Otolaryngol Suppl: 67\u201370. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15513515<\/ext-link>. Accessed 2012 Oct 25.","DOI":"10.1080\/03655230410018336"},{"key":"ref17","volume":"23","unstructured":"Friedlander PL (2001) Genomic instability in head and neck cancer patients. Head Neck 23<\/volume>: : 683\u2013691. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11443752<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref18","volume":"355","unstructured":"Olaussen KA, Dunant A, Fouret P, Brambilla E, Andr\u00e9 F, et al<\/etal>.. (2006) DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 355<\/volume>: : 983\u2013991. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16957145<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref19","volume":"99","unstructured":"Jun HJ, Ahn MJ, Kim HS, Yi SY, Han J, et al<\/etal>.. (2008) ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation. Br J Cancer 99<\/volume>: : 167\u2013172. Available: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2453006&tool=pmcentrez&rendertype=abstract<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref20","volume":"38","unstructured":"Kang S, Ju W, Kim JW, Park NH, Song YS, et al<\/etal>.. (2006) Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer. Exp Mol Med 38<\/volume>: : 320\u2013324. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16819291<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref21","unstructured":"McNeil EM, Melton DW (2012) DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy. Nucleic Acids Res: 1\u201315. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22941649<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref22","volume":"12","unstructured":"Biggerstaff M, Szymkowski DE, Wood RD (1993) Co-correction of the ERCC1, ERCC4 and xeroderma pigmentosum group F DNA repair defects in vitro. EMBO J 12<\/volume>: : 3685\u20133692. Available: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=413645&tool=pmcentrez&rendertype=abstract<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref23","volume":"356","unstructured":"Niedernhofer LJ, Bhagwat N, Wood RD (2007) ERCC1 and non-small-cell lung cancer. N Engl J Med 356<\/volume>: : 2538\u201340; author reply 2540\u20131. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17568038<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref24","volume":"69","unstructured":"Bhagwat NR, Roginskaya VY, Acquafondata MB, Dhir R, Wood RD, et al<\/etal>.. (2009) Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue. Cancer Res 69<\/volume>: : 6831\u20136838. Available: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2739111&tool=pmcentrez&rendertype=abstract<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"K\u00f6berle B, Ditz C, Kausch I, Wollenberg B, Ferris RL, et al<\/etal>.. (2010) Metastases of squamous cell carcinoma of the head and neck show increased levels of nucleotide excision repair protein XPF in vivo that correlate with increased chemoresistance ex vivo: 1277\u20131284. doi:10.3892\/ijo","DOI":"10.3892\/ijo"},{"key":"ref26","volume":"9","unstructured":"Chiu T-J, Chen C-H, Chien C-Y, Li S-H, Tsai H-T, et al<\/etal>.. (2011) High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area. J Transl Med 9<\/volume>: : 31. Available: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3072326&tool=pmcentrez&rendertype=abstract<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref27","first-page":"34","article-title":"NIH Public Access","volume":"40","author":"Van Vugt MATM","year":"2011"},{"key":"ref28","volume":"9","unstructured":"Haraf DJ, Rosen FR, Stenson K, Argiris A, Mittal BB, et al<\/etal>.. (2003) Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Clin Cancer Res 9<\/volume>: : 5936\u20135943. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14676118<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref29","volume":"21","unstructured":"Vokes EE, Stenson K, Rosen FR, Kies MS, Rademaker AW, et al<\/etal>.. (2003) Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 21<\/volume>: : 320\u2013326. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12525525<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref30","volume":"10","unstructured":"Michiels S, Le Ma\u00eetre A, Buyse M, Burzykowski T, Maillard E, et al<\/etal>.. (2009) Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data. Lancet Oncol 10<\/volume>: : 341\u2013350. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19246242<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref31","volume":"119","unstructured":"Nanni S, Benvenuti V, Grasselli A, Priolo C, Aiello A, et al<\/etal>.. (2009) Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J Clin Invest 119<\/volume>: : 1093\u20131108. Available: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2673846&tool=pmcentrez&rendertype=abstract<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref32","volume":"16","unstructured":"Alexander BM, Sprott K, Farrow DA, Wang X, D'Andrea AD, et al<\/etal>.. (2010) DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer. Clin Cancer Res 16<\/volume>: : 5796\u20135804. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21138871<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref33","volume":"63","unstructured":"Ma PC, Kijima T, Maulik G, Fox EA, Sattler M, et al<\/etal>.. (2003) c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Cancer Res 63<\/volume>: : 6272\u20136281. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14559814<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref34","volume":"66","unstructured":"Jagadeeswaran R, Ma PC, Seiwert TY, Jagadeeswaran S, Zumba O, et al<\/etal>.. (2006) Functional analysis of c-Met\/hepatocyte growth factor pathway in malignant pleural mesothelioma. Cancer Res 66<\/volume>: : 352\u2013361. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16397249<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref35","volume":"68","unstructured":"Jagadeeswaran R, Surawska H, Krishnaswamy S, Janamanchi V, Mackinnon AC, et al<\/etal>.. (2008) Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer Res 68<\/volume>: : 132\u2013142. Available: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2767335&tool=pmcentrez&rendertype=abstract<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref36","volume":"65","unstructured":"Ma PC, Jagadeeswaran R, Jagadeesh S, Tretiakova MS, Nallasura V, et al<\/etal>.. (2005) Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. Cancer Res 65<\/volume>: : 1479\u20131488. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15735036<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref37","volume":"69","unstructured":"Seiwert TY, Jagadeeswaran R, Faoro L, Janamanchi V, Nallasura V, et al<\/etal>.. (2009) The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma. Cancer Res 69<\/volume>: : 3021\u20133031. Available: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2871252&tool=pmcentrez&rendertype=abstract<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref38","volume":"17","unstructured":"Vaezi A, Wang X, Buch S, Gooding W, Wang L, et al<\/etal>.. (2011) XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck. Clin Cancer Res 17<\/volume>: : 5513\u20135522. Available: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3156890&tool=pmcentrez&rendertype=abstract<\/ext-link>. Accessed 2014 March 12."},{"key":"ref39","volume":"132","unstructured":"Haddad R, Tishler R, Wirth L, Norris CM, Goguen L, et al<\/etal>.. (2006) Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 132<\/volume>: : 678\u2013681. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16785415<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref40","volume":"266","unstructured":"Dietz A, Rudat V, Dreyhaupt J, Pritsch M, Hoppe F, et al<\/etal>.. (2009) Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Eur Arch Otorhinolaryngol 266<\/volume>: : 1291\u20131300. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18972123<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref41","volume":"101","unstructured":"Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, et al<\/etal>.. (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101<\/volume>: : 498\u2013506. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19318632<\/ext-link>. Accessed 2012 Oct 25."},{"key":"ref42","volume":"40","unstructured":"Reinhardt HC, Hasskamp P, Schmedding I, Morandell S, van Vugt MATM, et al<\/etal>.. (2010) DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization. Mol Cell 40<\/volume>: : 34\u201349. Available: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3030122&tool=pmcentrez&rendertype=abstract<\/ext-link>. Accessed 2014 Feb 20."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0102112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:52:50Z","timestamp":1540342370000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0102112"}},"subtitle":[],"editor":[{"given":"Apar Kishor","family":"Ganti","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,14]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0102112","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,14]]}}}